Does Rallies show 13F holders for OKUR?

Yes. Rallies tracks hedge fund and 13F ownership data for OKUR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is OKUR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OKUR. It does not provide personalized investment advice.

OKUR (OnKure Therapeutics, Inc. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is a publicly traded Healthcare sector company. As of May 21, 2026, OKUR trades at $3.64 with a market cap of $124.42M and a P/E ratio of -0.83. OKUR moved +8.18% today. Year to date, OKUR is +24.04%; over the trailing twelve months it is +53.45%. Its 52-week range spans $1.70 to $20.00. Analyst consensus is strong buy with an average price target of $24.33. Rallies surfaces OKUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns OKUR stock?

Hedge funds tracked by Rallies that own OKUR include Highbridge Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for OnKure Therapeutics, Inc. Class A Common Stock.

OKUR Key Metrics

Key financial metrics for OKUR
Metric	Value
Price	$3.64
Market Cap	$124.42M
P/E Ratio	-0.83
EPS	$-4.33
Dividend Yield	0.00%
52-Week High	$20.00
52-Week Low	$1.70
Volume	17
Avg Volume	0
Revenue (TTM)	$2.82M
Net Income	$-58.75M
Gross Margin	0.00%

Top Hedge Funds Holding OKUR

Highbridge Capital holds 542.36K shares of OKUR, changed -16.59% as of Dec 31, 2025.

Latest OKUR News

OnKure Secures $150M, Advances OKI-355 and OKI-345 Candidates — May 5, 2026
OnKure Raises $150M to Fund PI3Kα Inhibitor IND Filings in 2027 — Mar 27, 2026
OnKure Therapeutics Reports $59.1M Cash, Reduces Q4 Loss to $13.5M — Mar 12, 2026

Recent OKUR Insider Trades

Saccomano Nicholas A sold 86 (~$357.459) on Mar 23, 2026.
Leverone Jason A. sold 301 (~$1.25K) on Mar 23, 2026.
Saccomano Nicholas A sold 87 (~$258.19) on Dec 22, 2025.

OKUR Analyst Consensus

4 analysts cover OKUR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.33.

Common questions about OKUR

Who owns OKUR stock?: Hedge funds tracked by Rallies that own OKUR include Highbridge Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for OnKure Therapeutics, Inc. Class A Common Stock.
Does Rallies show 13F holders for OKUR?: Yes. Rallies tracks hedge fund and 13F ownership data for OKUR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OKUR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OKUR. It does not provide personalized investment advice.